Ayurveda: Evidence Review
Summary
The Cochrane Collaboration and other systematic review bodies have evaluated the evidence base for Ayurvedic interventions across multiple conditions. Reviews cover Ayurvedic herbal preparations, dietary recommendations, Panchakarma detoxification, and constitutional assessment methods. The overall evidence landscape is mixed, with some interventions showing promise and many others requiring better-designed trials.
Key findings
Systematic reviews, including Cochrane reviews, of Ayurvedic treatments for rheumatoid arthritis, type 2 diabetes, and hyperlipidemia have generally found insufficient evidence, with a few small trials showing preliminary positive results. Turmeric (curcumin) extracts have shown anti-inflammatory effects in small trials. Ashwagandha (Withania somnifera) has shown adaptogenic/anti-stress effects in small controlled studies, largely from single research groups. However, methodological quality across Ayurvedic clinical trials remains generally low.
Methodology
Systematic reviews follow standard Cochrane protocols, searching major medical databases for randomized controlled trials. Inclusion criteria require comparison with placebo or conventional treatment. Many included studies originate from Indian research institutions, raising questions about generalizability and reporting bias.
Criticism / Limitations
The majority of Ayurvedic clinical trials suffer from inadequate randomization, blinding, and sample size. Publication bias favors positive results, particularly from studies published in Indian journals. Standardization of Ayurvedic preparations across studies is inconsistent, making meta-analysis difficult.
Verification notes
Individual herbal constituents like curcumin have strong evidence from independent pharmacological research. Broader claims about Ayurvedic treatment systems require more rigorous evidence. Safety concerns about heavy metal contamination in some traditional preparations are well-documented.
- Audited against Wikipedia (September 2026).